Filson, Darren; Oweis, Ahmed - In: Journal of Health Economics 29 (2010) 4, pp. 575-584
Court decisions in 1998 encouraged generic producers to pursue Paragraph IV patent challenges. A follow-up decision in 2000 marked the first successful challenge involving a blockbuster and brought further attention to this pathway for generic entry. We consider the impacts of these decisions on...